<DOC>
	<DOCNO>NCT02248220</DOCNO>
	<brief_summary>Assessment daily maintenance dose Sifrol® , L-dopa spar effect , effect tremor , depression , anhedonia tolerability</brief_summary>
	<brief_title>Efficacy Tolerability Sifrol® ( Pramipexole ) Patients With Advanced Idiopathic Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Patients advance idiopathic Parkinson 's disease combine treatment Sifrol Ldopa indicate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>